| 11/6/2024 | CV | Market Commentary: Digital Realty convertible notes offering eyed; TeraWulf up; Exact Sciences contracts
|
| 7/29/2024 | CV | Market Commentary: Guardant Health convertibles improve; Ford down outright, holds dollar-neutral gains
|
| 5/9/2024 | CV | Market Commentary: Pacira BioSciences convertibles eyed; Snap notes in demand; Exact Sciences lower
|
| 4/12/2024 | CV | Market Commentary: Convertibles action thins; Rivian Automotive notes decline; Royal Caribbean pressured
|
| 4/11/2024 | CV | Market Commentary: Exact Sciences exchanges; NextEra active; Western Digital, Super Micro convertibles gain
|
| 4/11/2024 | CVLM | Exact Sciences enters exchange agreement for 0.375% convertibles
|
| 4/2/2024 | CV | Market Commentary: High-grade convertible notes come in amid weak market conditions; Exact Sciences firms
|
| 3/28/2024 | CV | Market Commentary: Convertibles secondary ends quarter on firm footing; Rexford adds outright; OPKO rises
|
| 10/4/2023 | CV | Market Commentary: Rivian reopens convertibles primary; Duke Energy, CMS Energy, Southern Co. notes gain
|
| 10/4/2023 | CV | Market Commentary: Morning Commentary: Duke Energy convertible notes in focus; Exact Sciences active
|
| 6/21/2023 | CV | Market Commentary: Cerence, World Kinect convertibles on tap; Lumentum lower; Exact Sciences volatile
|
| 2/23/2023 | CVLM | Exact Sciences enters exchange agreement for two convertibles
|
| 2/23/2023 | CV | New Issue: Exact Sciences places $500 million 2% convertibles due 2030, up 25%
|
| 1/9/2023 | CV | Market Commentary: Live Nation convertible notes upsized amid heavy demand; talk tightens; Bilibili active
|
| 12/20/2022 | CV | Market Commentary: Lucid convertible notes gain; MicroStrategy, Marathon Digital, Exact Sciences active
|
| 12/20/2022 | CV | Market Commentary: Morning Commentary: Exact Sciences convertible notes remain in focus; shares improve
|
| 12/19/2022 | CV | Market Commentary: Investment-grade convertibles in focus; Axon drifts lower; Exact Sciences holds gains
|
| 12/16/2022 | CV | Market Commentary: Novavax volatile outright, mixed on hedge; Guardant Health down; Exact Sciences up
|
| 1/11/2021 | CV | Market Commentary: Nio, DocuSign convertible notes on tap; Box tightens talk; Exact Sciences improves
|
| 10/28/2020 | CV | Market Commentary: Morning Commentary: Convertibles secondary quiet as stocks drop; Korea’s Kakao eyed
|
| 10/27/2020 | CV | Market Commentary: Exact Sciences convertibles in focus; K12 notes improve; Chegg trades down outright
|
| 10/27/2020 | CV | Market Commentary: Morning Commentary: Exact Sciences convertibles eyed; K12 notes gain post earnings
|
| 3/2/2020 | CV | Market Commentary: Square’s $1 billion convertibles, GFL offering eyed; RingCentral, Exact Sciences lower
|
| 2/28/2020 | CV | Market Commentary: RingCentral prices $1 billion, contracts on debut; Exact Sciences, NuVasive down again
|
| 2/27/2020 | CV | Exact Sciences greenshoe ups eight-year convertibles to $1.15 billion
|
| 2/27/2020 | CV | Market Commentary: RingCentral on tap; NuVasive contracts on debut; Bandwidth, Exact Sciences below par
|
| 2/26/2020 | CV | Market Commentary: NuVasive convertible offering eyed; Bandwidth expands on debt; Exact Sciences volatile
|
| 2/25/2020 | CV | Market Commentary: GFL units on tap; Bandwidth convertible offering eyed; Exact Sciences notes volatile
|
| 2/25/2020 | CV | Market Commentary: Morning Commentary: Bandwidth convertible offering eyed; Exact Sciences expands on debut
|
| 2/25/2020 | CV | New Issue: Exact Sciences sells upsized $1 billion eight-year convertibles at 0.375%, up 27.5%
|
| 2/24/2020 | CV | Market Commentary: Exact Sciences brings overnight deal; convertibles secondary market weak; Tesla active
|
| 2/24/2020 | CV | Exact Sciences talks $850 million 0.375% eight-year convertible notes at par, up 27.5%
|
| 1/13/2020 | CV | Market Commentary: Luckin Coffee convertible notes in focus; MongoDB gains continue; Exact Sciences down
|
| 10/31/2019 | CV | Market Commentary: Wayfair convertibles slide outright after earnings disappoint; Western Digital contracts
|
| 10/31/2019 | CV | Market Commentary: Morning Commentary: Earnings onslaught in focus; Wayfair, Western Digital, Etsy trade
|
| 10/30/2019 | CV | Market Commentary: Winnebago expands in first-day trading; Granite flat; DTE Energy mandatory trades well
|
| 10/1/2019 | CV | Market Commentary: Wayfair, Nio, Valaris slide with shares after dour ISM number; some names struggle
|
| 10/1/2019 | CV | Market Commentary: Morning Commentary: NXP Semiconductors, Pinduoduo convertibles active in early trading
|
| 9/24/2019 | CV | Market Commentary: Broadcom to price $3 billion of mandatories overnight; Lannett on tap; Pinduoduo eyed
|
| 9/24/2019 | CV | Market Commentary: Morning Commentary: Planned Pinduoduo convertible notes in focus; Exact Sciences eyed
|
| 7/29/2019 | CV | Market Commentary: Western Digital convertibles active; Turning Point up; Exact Sciences down outright
|
| 7/29/2019 | CV | Market Commentary: Morning Commentary: Western Digital convertibles eyed; Exact Sciences down outright
|
| 5/15/2019 | CV | Market Commentary: Avantor convertible preferreds on tap; Exact Sciences, Tesla active in secondary trading
|
| 5/15/2019 | CV | Market Commentary: Morning Commentary: Avantor convertible preferreds on tap; Exact Sciences in focus
|
| 3/27/2019 | CV | Market Commentary: iQIYI’s $1.05 billion convertible notes expand on debut; Exact Sciences trades below par
|
| 3/8/2019 | CV | Exact Sciences greenshoe ups 0.375% convertibles to $747.5 million
|
| 3/7/2019 | CV | Market Commentary: Pluralsight convertibles dominate secondary, expand on debut; Exact Sciences keeps expanding
|
| 3/7/2019 | CV | Market Commentary: Morning Commentary: Pluralsight convertibles dominate secondary, trade up on debut
|
| 3/6/2019 | CV | Market Commentary: Pluralsight on tap; Ares Capital wrapped around issue price; Exact Sciences expands
|
| 3/6/2019 | CV | Market Commentary: Morning Commentary: Ares Capital, Exact Sciences price convertible notes at discounts
|
| 3/6/2019 | CV | New Issue: Exact Sciences sells $650 million 0.375% eight-year convertibles at 99.5, up 27.5%
|
| 3/5/2019 | CV | Market Commentary: Exact Sciences on tap; Pluralsight looks cheap; Ares Capital reprices; Ctrip.com in focus
|
| 3/5/2019 | CV | Exact Sciences to price $600 million 0.375% eight-year convertibles at 99.5, up 27.5%
|
| 1/23/2019 | CV | Market Commentary: ConMed convertibles on tap; Tilray up; Exact Sciences expands; Citrix, Illumina active
|
| 1/7/2019 | CV | Market Commentary: Convertibles secondary tone improves; Ares Capital dominates trading; biotechs strong
|
| 10/31/2018 | CV | Market Commentary: Clovis convertibles clobbered; Exact Sciences, FireEye improve; Weatherford rebounds
|
| 10/18/2018 | CV | Market Commentary: Evolent Health hits the market; Aegean Marine notes eyed; Ligand, Exact Sciences active
|
| 8/28/2018 | CV | Market Commentary: Biotech names eyed; Wright Medical convertibles up; Exact Sciences reaches new heights
|
| 8/23/2018 | CV | Market Commentary: MercadoLibre better; Momo brushes par; Illumina levels ‘baffling’; Exact Sciences eyed
|
| 8/23/2018 | CV | Market Commentary: Morning Commentary: MercadoLibre better outright; Cree flat; Exact Sciences in focus
|
| 8/22/2018 | CV | Market Commentary: MercadoLibre, Cree hit market with $1.3 billion of convertibles; Exact Sciences expands
|
| 8/2/2018 | CV | Market Commentary: Greenlight Capital convertibles eyed; Tesla improves; Exact Sciences gets hammered
|
| 6/12/2018 | CV | Exact Sciences greenshoe lifts 1% convertible add-on to $218.5 million
|
| 6/8/2018 | CV | Market Commentary: Convertibles primary prices $1.06 billion; Vishay, Mindbody, Exact Sciences active
|
| 6/8/2018 | CV | Market Commentary: Morning Commentary: Primary prices $1.06 billion; Vishay, Mindbody, Exact Sciences hit the market
|
| 6/8/2018 | CV | New Issue: Exact Sciences prices upsized $190 million add-on to 1% convertible notes at 106.5
|
| 6/7/2018 | CV | Exact Sciences announces $150 million add-on to 1% convertible notes
|
| 5/30/2018 | CV | Market Commentary: Market eyes GDS convertibles; Exact Sciences reaches new heights; Microchip active
|
| 4/27/2018 | CV | Market Commentary: Western Digital active; AXA offering gets ‘positive reception’; Exact Sciences rebounds
|
| 4/17/2018 | CV | Market Commentary: South Jersey, Deutsche on tap; Clovis convertibles ‘well received’; oil still catching bids
|
| 4/12/2018 | CV | Market Commentary: Transocean convertibles in focus; primary quiet; biotech sector firm; Caesars active
|
| 3/19/2018 | CV | Market Commentary: Apptio convertibles on tap; Guidewire, Zendesk waver below par; Exact Sciences down
|
| 3/14/2018 | CV | Market Commentary: Zendesk, Supernus on tap; Helix Energy convertibles price cheap, dominate trading
|
| 2/26/2018 | CV | Market Commentary: Convertibles market opens slowly, picks up in afternoon; Q2, Okta active; biotechs improve
|
| 2/23/2018 | CV | Market Commentary: Okta’s convertibles expand on debut; Q2 trading activity tempers; Exact Sciences lower
|
| 2/23/2018 | CV | Market Commentary: Morning Commentary: Okta’s new convertible notes expand on debut; Exact Sciences continues slide
|
| 2/12/2018 | CV | Market Commentary: Iconix convertibles jump on exchange; Western Digital improves; Endeavour above par
|
| 2/2/2018 | CV | Market Commentary: Convertibles settle down; ‘rough tape’ for recent biotech deals; Lam Research tumbles
|
| 2/2/2018 | CV | Market Commentary: Morning Commentary: Convertibles market settles down; ‘rough tape’ for recent biotech deals
|
| 1/23/2018 | CV | Market Commentary: Teekay eyes deal; Insmed seen as cheap; new paper active; Priceline gains on new CFO
|
| 1/22/2018 | CV | Market Commentary: Insmed eyes deal; secondary market ‘not moving’; Exact Sciences, optic companies lose footing
|
| 1/22/2018 | CV | Market Commentary: Morning Commentary: Convertibles ‘not moving’ in early trading; Exact Sciences loses footing
|
| 1/18/2018 | CV | Market Commentary: Nutanix, Patrick Industries expand on debut; Exact Sciences rebounds; Coupa gains
|
| 1/17/2018 | CV | Exact Sciences greenshoe ups 1% convertibles due 2025 to $690 million
|
| 1/17/2018 | CV | Market Commentary: Nutanix, Patrick convertibles eyed; Genocea prices; Exact Sciences is ‘murder today’
|
| 1/17/2018 | CV | Market Commentary: Morning Commentary: Nutanix, Patrick deals seen cheap, Exact Sciences is ‘murder today’
|
| 1/16/2018 | CV | Market Commentary: Nutanix, Patrick, Genocea Biosciences to price new deals; Coupa, Exact Sciences quiet; Blackhawk active
|
| 1/16/2018 | CV | Market Commentary: Morning Commentary: Secondary market off to a slow start; Coupa sees modest expansion
|
| 1/12/2018 | CV | Market Commentary: Exact Sciences, Coupa dominate trading activity; December’s deals going strong
|
| 1/12/2018 | CV | Market Commentary: Morning Commentary: Exact Sciences, Coupa bring new paper to market
|
| 1/12/2018 | CV | New Issue: Exact Sciences prices upsized $600 million seven-year 1% convertibles at 98.75
|
| 1/11/2018 | CV | New Issue: Exact Sciences prices upsized $600 million seven-year convertibles at 1%, up 37%
|
| 1/11/2018 | CV | Market Commentary: Exact Sciences to price $500 million; market awaits Coupa; Wheeler adds on; AmTrust active
|
| 1/11/2018 | CV | Exact Sciences talks $500 million seven-year convertibles at fixed coupon, premium of 1%, up 37%
|
| 8/17/2010 | CVHYPF | Exact Sciences files $150 million shelf for stock, preferreds, debt
|
| 11/19/2007 | CVHY | Exact Sciences files $50 million shelf
|
